Insider · CIK 0001264783
GROENHUYSEN WILHELMUS CM
Reports to the SEC for 3 companies · YARDLEY, PA
Transactions
50
Companies
3
Filings
8
CIK
0001264783
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-05-21 | OptiNose, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-05-21 | OptiNose, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-05-21 | OptiNose, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-05-21 | OptiNose, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-05-21 | OptiNose, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-05-21 | OptiNose, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-05-21 | OptiNose, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-05-21 | OptiNose, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-06-28 | NVCRNovoCure LtdA Award | +$12.9K |
| 2024-06-06 | OptiNose, Inc.Stock Option (Right to Buy)A Award | — |
| 2024-06-05 | NVCRNovoCure LtdM Exercise/Conversion | +$2.84M |
| 2024-06-05 | NVCRNovoCure Ltd · Stock Options (Right to buy)M Exercise/Conversion | −$2.84M |
| 2024-03-04 | NVCRNovoCure LtdS Sale | −$19.5K |
| 2024-03-01 | NVCRNovoCure LtdS Sale | −$33.8K |
| 2024-02-28 | NVCRNovoCure LtdS Sale | −$37.2K |
| 2024-02-27 | NVCRNovoCure LtdA Award | +$767K |
| 2024-02-27 | NVCRNovoCure Ltd · Stock Options (Right to buy)A Award | +$1.17M |
| 2023-12-31 | NVCRNovoCure LtdA Award | +$38.07 |
| 2023-09-01 | NVCRNovoCure LtdS Sale | −$6,414.257 |
| 2023-06-30 | NVCRNovoCure LtdA Award | +$12.9K |
| 2023-06-08 | OptiNose, Inc.Stock Option (Right to Buy)A Award | — |
| 2023-03-03 | NVCRNovoCure LtdA Award | — |
| 2023-03-03 | NVCRNovoCure LtdA Award | — |
| 2023-03-03 | NVCRNovoCure LtdS Sale | −$269K |
| 2023-03-03 | NVCRNovoCure LtdS Sale | −$129K |
| 2023-03-03 | NVCRNovoCure LtdS Sale | −$1.55M |
| 2023-03-02 | NVCRNovoCure LtdS Sale | −$91.3K |
| 2023-03-01 | NVCRNovoCure LtdS Sale | −$165K |
| 2023-02-28 | NVCRNovoCure LtdA Award | — |
| 2023-02-28 | NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award | +$2.77M |
| 2023-01-06 | NVCRNovoCure LtdA Award | +$6,355.11 |
| 2022-09-02 | NVCRNovoCure LtdS Sale | −$23.4K |
| 2022-07-05 | NVCRNovoCure LtdA Award | +$12.9K |
| 2022-06-08 | OptiNose, Inc.Stock Option (Right to Buy)A Award | — |
| 2022-05-05 | NVCRNovoCure Ltd · Options to Buy Ordinary SharesG Gift | — |
| 2022-05-05 | NVCRNovoCure Ltd · Options to Buy Ordinary SharesG Gift | — |
| 2022-03-08 | NVCRNovoCure LtdS Sale | −$205K |
| 2022-03-04 | NVCRNovoCure LtdS Sale | −$181K |
| 2022-03-03 | NVCRNovoCure LtdA Award | — |
| 2022-03-03 | NVCRNovoCure LtdS Sale | −$96.9K |
| 2022-03-03 | NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award | +$3.09M |
| 2022-03-03 | NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award | +$618K |
| 2022-01-06 | NVCRNovoCure LtdA Award | +$4,786.35 |
| 2021-09-02 | NVCRNovoCure LtdS Sale | −$25K |
| 2021-08-10 | NVCRNovoCure Ltd · Options to Buy Ordinary SharesG Gift | — |
| 2021-08-10 | NVCRNovoCure Ltd · Options to Buy Ordinary SharesG Gift | — |
| 2021-07-06 | NVCRNovoCure LtdA Award | +$9,050.052 |
| 2021-06-09 | OptiNose, Inc.Stock Option (Right to Buy)A Award | — |
| 2021-03-08 | NVCRNovoCure LtdS Sale | −$393K |
| 2021-03-04 | NVCRNovoCure LtdS Sale | −$530K |
Recent filings
- 4GROENHUYSEN WILHELMUS CM0001104659-25-051346SEC(opens sec.gov)
- 4GROENHUYSEN WILHELMUS CM0001562180-24-006042SEC(opens sec.gov)
- 4GROENHUYSEN WILHELMUS CM0001562180-24-004824SEC(opens sec.gov)
- 4GROENHUYSEN WILHELMUS CM0001494650-24-000087SEC(opens sec.gov)
- 4GROENHUYSEN WILHELMUS CM0001562180-24-002248SEC(opens sec.gov)
- 4GROENHUYSEN WILHELMUS CM0001562180-24-001980SEC(opens sec.gov)
- 4GROENHUYSEN WILHELMUS CM0001562180-23-006683SEC(opens sec.gov)
- 4GROENHUYSEN WILHELMUS CM0001562180-23-005761SEC(opens sec.gov)
Companies
Address
C/O OPTINOSE, INC. 777 TOWNSHIP LINE ROAD, SUITE 300
YARDLEY, PA, 19067